Stephens Cuts Simulations Plus (NASDAQ:SLP) Price Target to $20.00

Simulations Plus (NASDAQ:SLP) had its price objective reduced by Stephens from $28.00 to $20.00 in a research report report published on Tuesday,Benzinga reports. They currently have an overweight rating on the technology company’s stock.

Several other brokerages have also recently commented on SLP. Wall Street Zen upgraded shares of Simulations Plus from a “sell” rating to a “hold” rating in a research note on Monday, April 28th. Craig Hallum decreased their price target on shares of Simulations Plus from $45.00 to $36.00 and set a “buy” rating on the stock in a research note on Friday, June 13th. William Blair restated an “outperform” rating on shares of Simulations Plus in a research report on Tuesday, June 3rd. JMP Securities reissued a “market perform” rating on shares of Simulations Plus in a research report on Wednesday, June 18th. Finally, KeyCorp lowered shares of Simulations Plus from an “overweight” rating to a “sector weight” rating in a research report on Tuesday. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $26.50.

Simulations Plus Price Performance

Shares of SLP stock opened at $12.79 on Tuesday. Simulations Plus has a 1 year low of $12.62 and a 1 year high of $43.40. The firm has a fifty day moving average price of $23.80 and a 200-day moving average price of $28.08. The company has a market cap of $257.46 million, a price-to-earnings ratio of -4.06 and a beta of 0.83.

Simulations Plus (NASDAQ:SLP) last issued its quarterly earnings data on Monday, July 14th. The technology company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.26 by $0.19. The firm had revenue of $20.36 million during the quarter, compared to the consensus estimate of $22.83 million. Simulations Plus had a negative net margin of 78.63% and a positive return on equity of 11.62%. The company’s revenue for the quarter was up 9.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.27 EPS. Equities research analysts expect that Simulations Plus will post 1.09 EPS for the current year.

Insider Activity

In related news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $33.51, for a total transaction of $670,200.00. Following the transaction, the director directly owned 3,344,157 shares in the company, valued at approximately $112,062,701.07. The trade was a 0.59% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 19.40% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Simulations Plus

Several institutional investors and hedge funds have recently bought and sold shares of the company. Jones Financial Companies Lllp raised its stake in shares of Simulations Plus by 53.6% in the 4th quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company’s stock valued at $34,000 after acquiring an additional 427 shares during the period. Fifth Third Bancorp raised its holdings in shares of Simulations Plus by 33.8% in the 1st quarter. Fifth Third Bancorp now owns 1,485 shares of the technology company’s stock valued at $36,000 after purchasing an additional 375 shares in the last quarter. Johnson Financial Group Inc. purchased a new stake in shares of Simulations Plus during the 4th quarter worth $39,000. Tower Research Capital LLC TRC lifted its position in shares of Simulations Plus by 42.2% during the 4th quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company’s stock worth $72,000 after purchasing an additional 764 shares during the last quarter. Finally, AlphaQuest LLC lifted its position in shares of Simulations Plus by 502.9% during the 4th quarter. AlphaQuest LLC now owns 2,689 shares of the technology company’s stock worth $75,000 after purchasing an additional 2,243 shares during the last quarter. 78.08% of the stock is currently owned by institutional investors and hedge funds.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.